FDA Approves Larotrectinib for Advanced Cancers that Expresses TRK Precision medicine took the spotlight again last week as the Federal Drug Administration (FDA) approved the drug larotrectinib (Vitrakvi(r)) developed by Bayer and Loxo Oncology. According to the FDA, larotrectinib is approved for adults (pill form)…
Read Full PostWith the holidays amongst us, it’s a great time to discuss all things family health history. While you’re sitting around the table gobbling down turkey, or snuggling by the fire wrapping presents, it’s important to understand your family history, and if you may be at…
Read Full Post
I joined Fight CRC in October 2018. Prior to that, I worked for Central Care Cancer Center as the Marketing Manager for their Missouri location. I also have over eight years of marketing and event planning experience through past experiences in Minor League Baseball and…
Read Full Post
The past four years have been unbelievable. I started with Fight CRC four years ago as an intern while I finished my last year of college. After graduation, I joined the staff full time and was welcomed into this community with open arms. Throughout the…
Read Full Post
While hair loss is not a life-threatening condition and it is not physically painful, it can affect a person’s mental health–elevating stress and anxiety and reducing quality of life. Specifically, the literature suggests that female-identified cancer patients, in particular, experience challenges with hair loss on…
Read Full Post
Meet Aubree Thelen, Fight CRC’s new Advocacy Manager I have big shoes to fill as I step into Fight CRC’s Advocacy Manager position. While I am not a survivor myself, cancer has touched my life and the people I love. Watching the personal struggle of…
Read Full Post
On October 19-23, global leaders gathered in Munich, Germany for the 2018 European Society for Medical Oncology (ESMO) conference to advance the science of cancer care, understand where the research currently stands, and disseminate knowledge within the oncology field. ESMO is the equivalent of the…
Read Full Post
Fight Colorectal Cancer (Fight CRC) has once again been selected by No-Shave November as one of the three recipients for all funds raised during the 2018 campaign. No-Shave November is a nonprofit organization encouraging men and women to “let it grow” during the month of…
Read Full PostFight Colorectal Cancer (Fight CRC) is excited to award this year’s research grant to Dr. Christine Molmenti from the Feinstein Institute for Medical Research at Northwell Health and Heather Hampel from the University of Ohio. Their research, titled “A feasibility study to determine history of…
Read Full Post
Earlier this year, the Trump Administration finalized a rule expanding short-term limited-duration health plans. As a reminder, these health plans do not have to comply with many of the Affordable Care Act’s (ACA) patient protections — they can exclude coverage for pre-existing conditions, impose lifetime…
Read Full Post